Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML

Clinical trial NCT00669890 · TERMINATED

Trial details

NCT number: NCT00669890
Sponsor: New York Medical College
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome

Start date: 2004-05-01
Primary completion: 2012-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.